Overview
TB-500 is a laboratory-synthesized peptide consisting of a 43–amino acid sequence that corresponds to thymosin beta-4 (Tβ4), a peptide extensively studied in cytoskeletal and cell-motility research. In experimental biology, thymosin beta peptides are commonly used to examine actin regulation, specifically the balance between monomeric (G-actin) and filamentous (F-actin) states, which underlies a wide range of cellular behaviors.
Within preclinical research systems, TB-500 has been applied in studies investigating cytoskeletal remodeling–dependent processes such as cell migration, neurite extension, endothelial cell function, and extracellular matrix (ECM) restructuring. Published experimental literature includes in-vitro assays and animal studies evaluating oxidative stress signaling, angiogenesis-related transcriptional activity, epithelial and stromal repair kinetics, and tissue remodeling outcomes under controlled conditions.
Molecular & Biochemical Properties
Amino Acid Sequence:
Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser
Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S
Molecular Weight: 4,963.44 g/mol
CAS Registry Number: 77591-33-4
PubChem CID: 16132341
TB-500 is a non-glycosylated, linear peptide with no disulfide bonds. Its biochemical behavior reflects the actin-binding characteristics of thymosin beta-4, supporting its use in studies focused on cytoskeletal organization and actin-dependent signaling networks.
Research Applications
TB-500 is utilized exclusively within laboratory research workflows to evaluate cytoskeleton-linked cellular phenotypes and signaling outputs. Common experimental applications include:
- Actin regulation studies, including G-actin sequestration, F-actin polymerization status, and stress-fiber organization
- Cell motility and adhesion assays, such as scratch-wound migration, transwell movement, and focal adhesion remodeling
- Endothelial and angiogenesis-related assays, including tube formation models and VEGF-axis transcriptional analysis
- Oxidative stress and innate signaling investigations, assessing pathway activity under defined cellular stressors
- Neural and glial cell models, evaluating neurite morphology, support-cell responses, and cytoskeletal remodeling
- Host–pathogen interaction studies in animal models, including quantitative microbial load measurements and inflammatory marker profiling
All experimental uses are limited to non-clinical research systems designed to explore fundamental biological mechanisms.
Mechanistic & Pathway Context
Thymosin beta peptides are classically characterized as actin-binding regulators that sequester G-actin, thereby influencing the pool of monomers available for filament formation. Because actin dynamics are integral to processes such as membrane protrusion, endocytosis, cytokinesis, and mechanotransduction, shifts in G-actin/F-actin balance can substantially alter cellular behavior.
Across preclinical models, TB-4 and TB-500–associated findings have been reported alongside modulation of angiogenic signaling programs, ECM-associated markers, and cellular stress-response pathways. In selected experimental systems, thymosin beta-4 has also been examined within oxidative stress and innate signaling frameworks, including studies evaluating pathway-linked mediators and viability indicators under controlled experimental stress conditions.
Summary of Preclinical Research Contexts
Neural Tissue & Support-Cell Models
In rodent spinal cord injury models, thymosin beta-4 has been evaluated using histological, vascular, and functional outcome measures to assess cellular responses within damaged neural tissue. Review literature further situates thymosin beta-4 within broader regenerative biology discussions, emphasizing mechanistic insights derived from preclinical evidence rather than clinical application.
In neural stem and progenitor cell models derived from spinal tissue, thymosin beta-4 has been studied under oxidative stress paradigms, with pathway-level readouts mapped to innate signaling axes such as TLR4/MyD88, including measurements of oxidative mediators and cell-viability indicators in vitro.
Vascular Biology, Angiogenesis & ECM Remodeling
Preclinical literature describes thymosin beta-4 as a participant in angiogenesis-associated programs, with reported relationships to VEGF-related signaling and vascular remodeling endpoints. Proposed mechanisms involve coordinated effects on cell migration, extracellular matrix restructuring, and endothelial or pericyte-associated processes, assessed through model-specific molecular and histological analyses.
Skin, Hair Follicle & Appendage Models
Mouse studies involving altered thymosin beta-4 expression have reported changes in hair follicle-associated phenotypes. Additional investigations have examined its role in stem-cell migration and differentiation readouts within skin and appendage-focused experimental systems.
Infection Models & Adjunct Biology
In murine models of Pseudomonas aeruginosa–induced keratitis, thymosin beta-4 has been studied alongside antibiotic treatment protocols. Reported endpoints include bacterial colony-forming unit (CFU) counts, neutrophil infiltration levels, and oxidative or inflammatory mediator measurements following defined treatment intervals.
Cardiovascular & Renal Experimental Systems
Research literature has explored thymosin beta-4–associated pathways in cardiovascular and renal models, with endpoints including angiogenic remodeling, endothelial migration, inflammatory signaling profiles, and fibrosis-related molecular markers. In myocardial ischemia paradigms, injectable hydrogel systems incorporating collagen and thymosin beta-4 have been evaluated using angiogenesis and epicardial cell migration readouts in preclinical designs.
Neurodegeneration-Adjacent Cellular Models
In HT22 neuronal cell experiments involving prion peptide exposure, thymosin beta-4 has been examined for its influence on autophagy-related signaling pathways and proteostasis-associated markers under defined in-vitro conditions.
Overall Summary
Across preclinical research literature, TB-4 and TB-500 are most frequently studied in the context of actin regulation, cytoskeletal remodeling, migration-related cellular behaviors, stress-response signaling, and tissue remodeling processes. Interpretation of experimental outcomes is inherently model-specific and dependent on study design variables such as dose, exposure route, timing, and assay methodology. This content is provided strictly for scientific reference and does not imply suitability for any non-research application.
Formulation & Analytical Considerations
TB-500 is supplied as a synthetic peptide intended for controlled laboratory use. Identity and traceability are commonly supported through sequence verification and registry identifiers such as CAS numbers and PubChem records. Standard research-grade qualification practices may include chromatographic purity assessment (e.g., HPLC-based analysis) and molecular mass confirmation using mass spectrometry, as part of internal laboratory quality control procedures.
Research Use Only (RUO) Notice
All products available on this website are supplied solely for in-vitro laboratory research purposes. In-vitro studies are conducted outside of living organisms under controlled experimental conditions.
These materials are not pharmaceuticals, drugs, or therapeutic agents and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, mitigation, or prevention of any disease or medical condition.
